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Abstract
PC12 cells that are differentiated with NGF and cAMP become totally dependent on these factors for their survival, unlike those that
are differentiated with NGF alone. We have asked whether the MAP Kinases, ERKs, JNKs and p38s play a role in the cell death induced
by withdrawal of trophic factors on NGF- and NGF/cAMP-differentiated PC12 cells. By Western-blot analyses with antibodies directed
against the activated forms of these kinases, we show that when the trophic factors were withdrawn, ERK phosphorylation was reduced to
very low levels within 1 h in both cases. Changes in the other enzymes were observed only in the NGF/cAMP-differentiated cells, in
which the JNK phosphorylation increased about 160% by 6 h and that of p38 increased linearly to at least 18-fold throughout the cell
death process. The increases in p38 and JNK phosphorylation were implicated in the death of the cells, since the p38 inhibitor PD169316
and the JNK inhibitor SP600125 were protective. These results demonstrate that the state of differentiation of PC12 cells, a model for the
differentiation of sympathetic neurons, determines their vulnerability to cell death by modifying the state of phosphorylation and the
regulation of specific kinases implicated in signal transduction pathways that are responsible for the survival or the death of these cells.
  2002 Elsevier Science B.V. All rights reserved.
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1 . Introduction cells, which acquire a neuronal phenotype in the presence
of NGF, have been shown to constitute an interesting
PC12 cells, derived from a rat pheochromocytoma [11], model for investigating the relationship between the state
have been widely used to study the molecular events of differentiation and the susceptibility to apoptosis in-
leading to neuronal differentiation. More recently, these duced by trophic factor withdrawal [21,22,27,29]. In the
presence of serum, PC12 cells divide and resemble pre-
cursors of adrenal chromaffin cells and sympathetic neu-
Abbreviations: ASK1, apoptosis signal-regulating kinase 1; BSA,
rons [11]. When treated with serum and NGF, PC12 cellsbovine serum albumin; (db)cAMP, (dibutyryl) cyclic adenosine mono-
undergo reversible neuronal differentiation; if NGF andphosphate; ERKs, extracellular signal-regulated kinases; JNKs, c-Jun
N-terminal kinases; MAP kinases, mitogen activated protein kinases; serum are removed from the culture medium, the cells die
MEK, MAP kinase kinase; MTT, 3-(4,5-dimethylthiazol-2-yl)-2,5- [22]. Chronic exposure of NGF-differentiated PC12 cells
diphenyltetrazolium bromide; NGF, nerve growth factor to a stable cell permeable analogue of cAMP potentiates
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their differentiation. The cell bodies become large, the2669.
neuritic arborization more elaborate and, most importantly,E-mail address: bernard.brugg@snv.jussieu.fr (B. Brugg).
1These authors contributed equally to this paper. they become dependent on NGF or cAMP for their
0169-328X/02/$ – see front matter   2002 Elsevier Science B.V. All rights reserved.
doi:10.1016/S0169-328X(02)00669-1
53N. Lambeng et al. / Molecular Brain Research 111 (2003) 52–60
survival and die, rather than dedifferentiate, when these ment with NGF and dbcAMP, culture medium was
factors are withdrawn [22,27]. changed every 2 days.
The molecular mechanisms involved in the switch that For deprivation experiments, the differentiation medium
renders NGF/cAMP-differentiated PC12 cells more sensi- was replaced on day 12 in vitro by the appropriate
tive to trophic factor withdrawal are not clearly estab- deprivation medium (see Section 3). Cell death was
lished. The MAP kinase cascades may, however, be quantified to ensure that trophic factor withdrawal caused a
expected to play an important role. These serine / threonine 50% decrease in survival after 48 or 24 h in NGF- and
kinases mediate intracellular signal transduction and can be NGF/cAMP-differentiated PC12 cells, respectively.
subdivided into three families (review in Refs. The following compounds were tested for their effects
[2,17,28,34]). The extracellular signal-regulated kinases on survival: the MEK inhibitor PD98059 (Alexis Corpora-
(ERKs) are activated by mitogens and growth factors and tion), the p38 inhibitor PD169316 and the JNK inhibitor
are mainly involved in cell proliferation and differentia- SP600125 (Calbiochem, La Jolla, CA, USA) used at
tion. The c-Jun N-terminal kinases (JNKs) and the p38 concentrations (100, 5, and 50 mM, respectively) de-
kinases are activated by proinflammatory cytokines, heat termined to be maximally effective (results not shown).
shock, hyperosmolarity and other cellular stresses, and
seem to be preferentially implicated in apoptotic processes 2 .2. Quantification of cell survival
[20,23,38–40]. The MAP kinases have been shown to be
differently regulated in NGF-differentiated PC12 cells Cells were incubated for 30 min at 37 8C with 250
during their death induced by NGF withdrawal [40]. mg/ml MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltet-
Whereas the ERK pathway was inhibited, the JNK and p38 razolium bromide, Sigma). The total number of cells and
signaling pathways were activated, leading to apoptosis. the number of viable cells containing the MTT reaction
These results encouraged us to evaluate whether ir- product were counted under bright field illumination at
reversible differentiation of PC12 cells with NGF and 103 magnification, in 10–20 randomly chosen fields
cAMP modifies the regulation of MAP kinases and their (Diaphot, Nikon), or the purple formazan salt was solubil-
activation during cell death induced by trophic factor ized in 100 ml of a solution containing 0.1 M HCl in
withdrawal. We show that ERK phosphorylation rapidly isopropanol and quantified by spectrophotometry at 560
decreases following trophic factor withdrawal in both cell nm.
types. In addition, in NGF/cAMP-differentiated cells, the
cell death process requires the phosphorylation of p38s and 2 .3. Analyses of kinase activationJNKs. The state of differentiation of the PC12 cells affects
the way in which the cells die, and thus their vulnerability
2 .3.1. Antibodiesto death inducing stimuli.
We used New England Biolabs (Beverly, MA, USA)
rabbit antisera specifically directed towards phospho-
202 204Thr -Tyr ERK1 (p44) diluted 1:2500, phospho-2 . Materials and methods 183 185 73Thr -Tyr JNK diluted 1:1000, Phospho-Ser c-Jun
180 182diluted 1:500, phospho-Thr -Tyr p38 diluted 1:200.2 .1. Cell culture
We also used rabbit polyclonal antisera (New England
Biolabs) raised against synthetic peptides specific for JNKPC12 cells were maintained in RPMI 1640 culture
diluted 1:1000 and for p38 diluted 1:1000, goat polyclonalmedium (Gibco BRL, Gaitherburg, MD, USA) with 5%
antisera (Santa Cruz Biotechnology) raised against syn-horse serum (Eurobio, Les Ulis, France), 10% fetal calf
thetic peptides specific for ERK2 diluted 1:4000.serum (Eurobio, Les Ulis, France), 60 mg/ml penicillin-G
and 100 mg/ml streptomycin in uncoated flasks. For
differentiation, the cells were plated in polyethyleneimine- 2 .3.2. Western-blot analyses
2
coated wells at a density of 1500 cells /cm as described Cultured PC12 cells were lysed in solubilization buffer
[22], and were maintained in L15 medium (Sigma, St. (10 mM Tris–HCl, 50 mM NaCl, 1% Triton X-100, 30
Louis, MO, USA) supplemented with 10% horse serum mM Na P O , 50 mM NaF, 5 mM ZnCl , 100 mM4 2 7 2
(Eurobio), 5% fetal calf serum and other additives as in Na VO , 1 mM dithiothreitol, 5 nM okadaic acid, 2.53 4
Ref. [19]. In order to induce differentiation, the cells were mg/ml aprotinin, 3.6 mM pepstatin, 0.5 mM phenyl-
exposed to 150 ng/ml NGF 2.5S (Alomone Labs, methylsulfonyl fluoride, 0.5 mM benzamidine, 5.3 mM
Jerusalem, Israel). Concentrations were determined by leupeptin) at 4 8C. Insoluble material was removed by
dose–response analyses to produce optimal differentiation centrifugation (13 0003g for 20 min at 4 8C) and samples
under our culture conditions (results not shown). After 7 were stored at 280 8C. The protein concentration was
days in the presence of NGF, the stable cell permeable determined with the DC protein assay kit (Bio-Rad). Cell-
cAMP analogue dibutyryl, dbcAMP (500 mM) was added extracts containing equivalent amounts of protein were
and differentiation continued for 4 days. During co-treat- boiled for 5 min in sample loading buffer. After a 10%
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SDS–PAGE, proteins were transferred onto a poly- caused a substantial decrease in p38 phosphorylation (Fig.
vinylidene difluoride membrane (ICN Biochemicals). Non- 1C), without significantly affecting the level of P-ERKs
specific protein binding sites were blocked with 5% and P-JNKs (Fig. 1A,B). Normalized P-p38 immuno-
skimmed milk for 2 h. Blots were then incubated overnight reactivity decreased upon irreversible differentiation with
at 4 8C with primary antibodies against the phosphorylated cAMP and reached 32610% of the value obtained for
form of the kinases, in 5% BSA. They were then incubated PC12 cells differentiated 1 week with NGF alone (Fig.
with horseradish peroxidase-conjugated secondary antibo- 1C).
dies in 5% skimmed milk for 1 h. Peroxidase activity was
revealed with the enhanced chemiluminescence substrate
(Amersham). The blots were then stripped with 0.1 M 3 .2. Trophic factor withdrawal induces a rapid decrease
glycine–HCl (pH 2.8) twice for 30 min at 60 8C and SDS of P-ERK in both types of PC12 cells
2% for 10 min, followed by saturation in 5% skimmed
milk overnight at 4 8C, then incubation with the primary As we previously showed [22], NGF-differentiated
antibody that recognizes both the phosphorylated and the PC12 cells die when NGF and serum are withdrawn from
non-phosphorylated forms of the kinases, in 5% skimmed the culture media, whereas NGF/cAMP-differentiated
milk. They were then incubated with secondary antibodies. cells die, even in the presence of serum, if both NGF and
The activity was revealed as described above. The results cAMP are withdrawn. To determine whether the state of
were quantified on the photographic films by densitometry differentiation of the PC12 cells modulates ERKs, JNKs or
using Densylab software (Microvision Instruments). The p38s during trophic factor withdrawal, we analyzed their
results are expressed as the ratio of the phosphorylated state of phosphorylation by Western-blotting. Our results
kinase to total kinase immunoreactivity (normalized P- showed a rapid decrease in normalized P-p44 and P-p42
kinase activity). immunoreactivity, in both NGF- and NGF/cAMP-dif-
ferentiated PC12 cells (Fig. 2A,B). The decrease in the
2 .3.3. Immunocytochemistry analyses level of phosphorylation of p44 and p42 was detected as
Cultured PC12 were fixed with PBS containing 4% early as 30 min after trophic factor withdrawal and, at 1 h,
paraformaldehyde for 20 min and then incubated with the values reached, respectively, 14.764.2 and 2.761.3%
methanol /acetone solution (50:50, v /v) for 10 min at 4 8C. of control values in NGF-differentiated PC12 cells and
After three washes in PBS, the plates were treated with 24.466.8 and 14.662.2% in NGF/cAMP-differentiated
permeabilisation buffer containing Triton X-100 0.2% in PC12 cells. In both cell types, the phosphorylation levels
PBS for 15 min and blocking buffer containing fetal calf of p44 and p42 remained low throughout the cell death
serum 10%, bovine serum albumin 3% in PBS for 30 min. process.
Polyclonal antibodies raised against Phospho-c-Jun To determine whether the decrease in ERK phosphoryla-
73(Ser c-Jun) (P-c-Jun, 1:500, New England Biolabs) were tion was responsible for the cell death observed after
incubated overnight at 4 8C in PBS containing 1% BSA, trophic factor withdrawal, we mimicked ERK downregula-
0.2% Triton X-100. The plates were then rinsed in PBS tion with PD98059 that inhibits MEK, the MAP kinase
and incubated with an anti-rabbit Cy3 conjugated antibody kinase responsible for ERK phosphorylation [5]. PD98059
(1:2000, Sigma) for 2 h and counterstained with bisben- inhibition of ERK phosphorylation had only a minimal
zimide. effect on the survival of NGF-differentiated PC12 cells
(Fig. 2C) and no effect on the survival of NGF/cAMP-
differentiated cells (Fig. 2D). Furthermore, it did not
3 . Results modulate the effect of trophic factor withdrawal on surviv-
al (Fig. 2C,D).
3 .1. p38 phosphorylation is down-regulated during
irreversible differentiation of NGF-differentiated PC12
cells with cAMP 3 .3. JNK is only activated during the death of NGF /
cAMP-differentiated PC12 cells and its inhibition
To follow kinase activation, cellular extracts of NGF- prevents cell death
and NGF/cAMP-differentiated PC12 cells were subjected
to Western-blot analyses, using antibodies directed against Western-blot analyses of JNK activation after trophic
the activated forms of the MAP kinases and against the factor withdrawal showed that removal of NGF/serum
total MAP kinases regardless of their phosphorylation from NGF-differentiated PC12 cells did not affect P-p54
state. The basal levels of phosphorylation of the ERKs, and P-p46 levels (Fig. 3A). However, P-p54 and P-p46
JNKs and p38s in PC12 cells differentiated by NGF or both increased during NGF/cAMP withdrawal in NGF/
NGF/cAMP are shown in Fig. 1. In comparison with cAMP-differentiated PC12 cells (Fig. 3B). This increase
differentiation by NGF alone, treatment of NGF-differen- reached 165% at 16 h for P-p54, and 189% at 16 h for
tiated PC12 cells with cAMP for an additional 4 days P-p46.
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Fig. 1. Effect of chronic cAMP treatment on PC12 cells on the MAP kinases. Western-blot analyses and quantification of P-ERK (P-p44 and P-p42) and
total ERK(total p44 and total p42) (A), P-JNK (P-p54 and P-p46) and total JNK (total p54 and total p46) (B) and P-p38 and total p38 (C) in extracts of
both NGF- and NGF/cAMP-differentiated PC12 cells. NGF- and NGF/cAMP-differentiated cells were analyzed on the same gel. Normalized P-MAPK
signals are the ratio of P-MAPK to total MAPK. Data represent the mean6S.E.M. of three independent experiments. * Significantly different from
NGF-differentiated PC12 cells (P,0.05, Student’s t-test). The immunoblots shown in D–F are from representative experiments.
To determine whether the increase in JNK phosphoryla- addition of NGF results in a modification of the cell death
tion was required for the cell death induced by trophic signal transduction pathway to include activation of JNK.
factor withdrawal in NGF/cAMP-differentiated PC12
cells, we inhibited the activity of this kinase with 3 .4. p38 is only activated during the death of NGF /
SP600125 [1,13]. To test this new inhibitor in differen- cAMP-differentiated PC12 cells and its inhibition
tiated PC12 cells, we performed an immunocytochemical prevents cell death
study of c-Jun phosphorylated on serine 63 (Fig. 4A–C,
E–G). We show that at 50 mM, SP600125 inhibited c-Jun We then analysed the kinetics of p38 phosphorylation
phosphorylation induced by 16 h of NGF/cAMP with- during the death of NGF- and NGF/cAMP-differentiated
drawal. In addition, SP600125 completely inhibited cell PC12 cells (Fig. 5A). No significant change in P-p38 levels
death in NGF/cAMP-differentiated PC12 cells quantified was observed in NGF-differentiated cells deprived of NGF
24 h after trophic factor withdrawal (Fig. 4I), showing that and serum. However, the withdrawal of NGF/cAMP from
irreversible differentiation of PC12 cells with cAMP in the culture medium of NGF/cAMP-differentiated cells
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Fig. 2. Withdrawal of trophic factors induces a decrease in ERK phosphorylation in both NGF- and NGF/cAMP-differentiated PC12 cells. Quantification
of Western-blot analyses of P-ERKs and total ERKs in extracts of NGF-differentiated PC12 cells deprived of NGF and serum (A) or NGF/cAMP-
differentiated PC12 cells deprived of NGF and cAMP (B). P-ERK signals were normalized to the corresponding total ERK signal and the percent
difference with respect to controls was calculated (P-p44 and P-p42). Data represent the mean6S.E.M. of three independent experiments. All the points are
significantly different from the control. * First time point significantly different from the control value (P,0.05, one-way ANOVA followed by Dunnett’s
test). (C,D) Effect of the MEK inhibitor PD98059 on survival after trophic factor withdrawal. Survival was assessed using the MTT assay on control cells
or after 48 h of NGF/serum withdrawal (C) or 24 h of NGF/cAMP withdrawal (D) with or without PD98059 (100 mM) treatment. Data represent the
mean6S.E.M. of three independent experiments, each performed in triplicate. * Significantly different from the control value (P,0.05, one-way ANOVA
[followed by Dunnett’s test). Values are not significantly different from each others.
induced a strong increase in p38 phosphorylation. This NGF/cAMP withdrawal and can be considered specific for
up-regulation began as early as 30 min after the treatment p38. This shows, as for JNK, that after irreversible
and reached 18-fold at 24 h. differentiation of PC12 cells, p38 activation becomes part
To determine whether the increase in p38 phosphoryla- of the cell death signal transduction pathway.
tion was involved in the cell death induced by trophic
factor withdrawal in NGF/cAMP-differentiated PC12
cells, we inhibited the activity of this kinase with 4 . Discussion
PD169316 [20]. At 5 mM, PD169316 completely inhibited
cell death in NGF/cAMP-differentiated PC12 cells quan- Although PC12 cells are commonly used to study the
tified 24 h after trophic factor withdrawal (Fig. 5B). To mechanisms of apoptosis induced by trophic factor with-
test whether this inhibitor also affected the JNK/c-Jun drawal, the molecular link between their neuronal differen-
pathway in differentiated PC12 cells, we performed an tiation and their differential susceptibility to loss of trophic
immunocytochemical study of c-Jun phosphorylated on support remains unclear. In this study, we found that the
serine 63 (Fig. 4D–H). We show that at 5 mM, PD169316 basal state of ERK, JNK and p38 activation differed
did not inhibit c-Jun phosphorylation induced by 16 h of depending on whether the cells were reversibly differen-
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ERK pathway in the death of both reversibly and irrever-
sibly differentiated PC12 cells.
Unlike the effects of trophic factor withdrawal on the
ERKs, which were independent of the state of differentia-
tion, JNK and p38 phosphorylation was observed after
trophic factor withdrawal only in NGF/cAMP-differen-
tiated cells. These results are consistent with the effects of
trophic factor withdrawal in mature neurons, such as
cerebellar granule neurons [36], sympathetic neurons
[7,24,35], and cortical neurons [38,39]. Activation of JNKs
has also been reported to occur after NGF deprivation in
PC12 cells [23,24,31,40], under culture and differentiation
conditions that differed from ours.
Withdrawal of NGF and cAMP resulted in a moderate
increase in JNK phosphorylation. This apparently small
activation could be due to dilution in whole cell homoge-
nates of activated nuclear JNKs, as suggested by Coffey et
al. [3]. SP600125, a pharmacological inhibitor of JNK,
totally prevented the cell death induced by trophic factor
withdrawal, highlighting the crucial role of this kinase in
the cell death process. A requirement for JNK activation
during cell death has also been described in other models,
such as PC12 cells [40] and sympathetic neurons [12]
deprived of NGF or cortical neurons treated with ceramide
[39].
Withdrawal of NGF and cAMP resulted in a large and
linear increase of p38 phosphorylation. PD169316, a
pharmacological inhibitor of p38, totally prevented the cell
death induced by trophic factor withdrawal, highlighting
the crucial role of this kinase in the cell death process. As
shown here and in several publications, this inhibitor of
p38 is specific and does not affect ERK or JNK/c-Jun
pathways [9,20]. Activation of p38 kinase during cell death
has also been described in other models, such as corticalFig. 3. Withdrawal of trophic factors induces an increase of JNK
neurons treated with ceramide [38] or chick neuronsphosphorylation only in NGF/cAMP-differentiated PC12 cells. Quantifi-
deprived of trophic factors [16].cation of Western-blot analyses of P-JNKs and total JNKs in extracts of
NGF-differentiated PC12 cells deprived of NGF and serum (A) or Since both p38s and JNKs are phosphorylated after
NGF/cAMP-differentiated PC12 cells deprived of NGF and cAMP (B). trophic factor withdrawal in our NGF/cAMP-differentiated
P-JNK signals were normalized to the corresponding total JNK signal and PC12 cells, it would be particularly interesting to de-the percent difference with respect to controls was calculated (P-p54 and
termine whether the protein kinase ASK1, that is reportedP-p46). Data represent the mean6S.E.M. of three independent experi-
to activate JNKs in NGF-differentiated PC12 cells [18], isments. * Time point significantly different from control value (P,0.05,
one-way ANOVA followed by Dunnett’s test). responsible for the activation of p38s and JNKs in our
model of cell death. Overexpression of this kinase is
indeed reported to induce death in NGF-differentiated
tiated with NGF alone or irreversibly differentiated with PC12 cells and in primary rat sympathetic neurons, and its
NGF and cAMP. As in our study, others have also shown down-regulation has been reported to reduce the neuronal
that p38 activation by growth factor is inhibited by cAMP death caused by NGF withdrawal [18].
[14], but cAMP can also activate p38s during neuronal The downstream signaling events that couple p38 activa-
differentiation of PC12 cells [25]. tion with neuronal cell death are still poorly understood.
We found that trophic factor withdrawal results in a Recent data have shown that monoamine oxidase is up-
large and rapid decrease in ERK phosphorylation in both regulated by p38 kinase and participates in cell death
NGF- and NGF/cAMP-differentiated cells, suggesting that induced by NGF withdrawal in PC12 cells [4]. The effect
chronic treatment with cAMP does not regulate the ERK of p38s may also be mediated by apoptotic effectors such
pathway. Inhibition of ERK phosphorylation neither re- as Bid which is cleaved upon p38 activation [41] or Bax,
produced nor increased the effect of trophic factor with- the activation of which and its translocation to mito-
drawal on survival. These results exclude a role for the chondria have been shown to be regulated by p38s [10].
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Fig. 4. Inhibition of JNK by SP600125 protects terminally-differentiated PC12 cells against cell death induced by trophic factor withdrawal. (A–H) The
JNK inhibitor SP600125 inhibits c-Jun phosphorylation on residue serine 63 induced by NGF/cAMP withdrawal. PC12 cell nuclei labeled with
bisbenzimide (A–D) and immunostained for P-c-Jun (E–H). NGF/cAMP-differentiated PC12 cells control (A,E), deprived of NGF/cAMP during 16 h
(B,C,D,F,G,H) and treated with the JNK inhibitor SP600125 (50 mM; C,G) or the p38 inhibitor PD169316 (5 mM; D,H). White arrows, normal nuclei;
arrowheads, corresponding P-c-Jun labeling; stars, condensed and fragmented nuclei. Scale bar: 10 mM. (I) The JNK inhibitor SP600125 prevents
phosphorylation of c-Jun and protects NGF/cAMP-differentiated PC12 cells from cell death induced by NGF and cAMP withdrawal. Survival was
assessed after 24 h of NGF and cAMP withdrawal from NGF/cAMP-differentiated cells, in the presence or absence of SP600125 (50 mM). Each bar
represents the mean6S.E.M. of 12 wells from two independent experiments. * Significantly different from control cells (P,0.0001, Student’s t-test).
Cyclic AMP inhibits the redistribution of Bax to the that, in NGF/cAMP-differentiated PC12 cells that re-
mitochondria and the resulting loss of cytochrome c when produce the terminal phase of differentiation of sympa-
sympathetic neurons are deprived of NGF, thus preventing thetic neurons, cell death induced by NGF/cAMP with-
cell death [32]. One might therefore speculate that cAMP drawal involves a balance between the MAP kinase
exerts these effects through inhibition of the p38 kinases, pathways: inhibition of ERK and activation of both JNK
and that NGF/cAMP withdrawal induces Bax transloca- and p38 pathways. These results are in accordance with the
tion and activation via p38s. pattern of regulation observed in cortical neurons treated
The pro-apoptotic action of JNK pathway in NGF/ by ceramide [38]. The present study highlights the crucial
cAMP withdrawal may be mediated by apoptotic effectors role of p38s and JNKs in the regulation of cell death
such as Fas-Ligand the expression of which is regulated by induced by trophic factor withdrawal in NGF/cAMP-
JNK [15,30]; the Fas-Ligand promoter contains an AP-1 differentiated PC12 cells. This effect might quite possibly
site that is a known target of the JNK pathway [8]. Bim, a be mediated through AP1 that is targeted by both the JNK
pro-apoptotic member of Bcl-2 family, which is strongly substrate c-Jun and the p38 substrate ATF2. Additional
induced in sympathetic neurons after NGF withdrawal, has investigations are needed to define the precise mechanisms
also been shown to be under the transcriptional control of by which cAMP regulates p38 phosphorylation, and the
the JNK pathway [33,37]. p38 isoforms involved. It would also be interesting to
In conclusion, in this study we showed for the first time determine whether the trophic effect of cAMP in PC12
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Neuril no. FMRX CT97-0149 and Biomed Cybrainet no.
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